Wall Street analysts expect Castlight Health Inc (NYSE:CSLT) to announce $36.65 million in sales for the current fiscal quarter, Zacks Investment Research reports. Three analysts have issued estimates for Castlight Health’s earnings, with estimates ranging from $36.39 million to $36.80 million. Castlight Health reported sales of $37.78 million during the same quarter last year, which would suggest a negative year over year growth rate of 3%. The firm is expected to issue its next quarterly earnings report on Monday, July 29th.

On average, analysts expect that Castlight Health will report full year sales of $154.61 million for the current fiscal year, with estimates ranging from $153.22 million to $155.60 million. For the next fiscal year, analysts forecast that the firm will post sales of $174.16 million, with estimates ranging from $167.19 million to $181.00 million. Zacks Investment Research’s sales averages are an average based on a survey of research firms that follow Castlight Health.

Castlight Health (NYSE:CSLT) last posted its earnings results on Thursday, February 28th. The software maker reported ($0.01) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.03) by $0.02. The firm had revenue of $42.10 million for the quarter, compared to analyst estimates of $40.61 million. Castlight Health had a negative return on equity of 11.47% and a negative net margin of 23.04%.

Separately, Zacks Investment Research lowered Castlight Health from a “hold” rating to a “sell” rating in a report on Tuesday, May 7th. One analyst has rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company. Castlight Health has a consensus rating of “Hold” and a consensus target price of $5.06.

Shares of Castlight Health stock traded down $0.11 during trading on Thursday, reaching $3.34. The stock had a trading volume of 509,400 shares, compared to its average volume of 448,127. The firm has a market cap of $496.66 million, a price-to-earnings ratio of -20.88 and a beta of 1.56. Castlight Health has a 52 week low of $1.86 and a 52 week high of $5.95. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.87 and a quick ratio of 1.87.

In other news, EVP Neeraj Gupta sold 8,738 shares of the business’s stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $3.61, for a total value of $31,544.18. Following the sale, the executive vice president now directly owns 275,255 shares in the company, valued at $993,670.55. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Over the last 90 days, insiders sold 32,538 shares of company stock worth $120,396. Corporate insiders own 17.37% of the company’s stock.

Institutional investors have recently modified their holdings of the company. Amalgamated Bank bought a new stake in shares of Castlight Health in the fourth quarter valued at about $25,000. Parametric Portfolio Associates LLC bought a new stake in shares of Castlight Health in the first quarter valued at about $63,000. BNP Paribas Arbitrage SA lifted its holdings in shares of Castlight Health by 847.1% in the first quarter. BNP Paribas Arbitrage SA now owns 18,174 shares of the software maker’s stock valued at $68,000 after purchasing an additional 16,255 shares in the last quarter. Virtu Financial LLC acquired a new stake in shares of Castlight Health in the first quarter valued at about $77,000. Finally, Two Sigma Investments LP acquired a new stake in shares of Castlight Health in the fourth quarter valued at about $51,000. Institutional investors own 51.81% of the company’s stock.

About Castlight Health

Castlight Health, Inc provides a software-as-a-service platform used for health benefits navigation for employees in the United States. Its platform matches employees to the resources their employers make available to them; managing a condition; and assists them to manage their benefits. The company also offers implementation, user and customer support, and marketplace services.

Further Reading: How Do Tariffs Affect Trade Balances?

Get a free copy of the Zacks research report on Castlight Health (CSLT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.